Foroutan, F.; Iorio, A.; Thabane, L.; Guyatt, G., Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interest, «JOURNAL OF CLINICAL EPIDEMIOLOGY», 2020, 117, pp. 46 - 51 [articolo]
Hay, C. R. M.; Shima, M.; Makris, M.; Jimenez-Yuste, V.; Oldenburg, J.; Fischer, K.; Iorio, A.; Skinner, M. W.; Santagostino, E.; Von Mackensen, S.; Kessler, C. M., Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company, «HAEMOPHILIA», 2020, 26, pp. 966 - 974 [articolo]
McEneny-King, A.; Yeung, C. H. T.; Edginton, A. N.; Iorio, A.; Croteau, S. E., Clinical application of Web Accessible Population Pharmacokinetic Service—Hemophilia (WAPPS-Hemo): Patterns of blood sampling and patient characteristics among clinician users, «HAEMOPHILIA», 2020, 26, pp. 56 - 63 [articolo]
Brian Haynes, R.; Del Fiol, G.; Michelson, M.; Iorio, A., Context and approach in reporting evaluations of electronic health record-based implementation projects, «ANNALS OF INTERNAL MEDICINE», 2020, 172, pp. 573 - 578 [articolo]
Konkle, B.; Pierce, G.; Coffin, D.; Naccache, M.; Clark, R. C.; George, L.; Iorio, A.; O'Mahony, B.; Pipe, S.; Skinner, M.; Watson, C.; Peyvandi, F.; Mahlangu, J., Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH, «JOURNAL OF THROMBOSIS AND HAEMOSTASIS», 2020, 18, pp. 3074 - 3077 [articolo]
Alexander, P. E.; Debono, V. B.; Mammen, M. J.; Iorio, A.; Aryal, K.; Deng, D.; Brocard, E.; Alhazzani, W., COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine, «JOURNAL OF CLINICAL EPIDEMIOLOGY», 2020, 123, pp. 120 - 126 [articolo]
Hajducek, D. M.; Chelle, P.; Hermans, C.; Iorio, A.; McEneny-King, A.; Yu, J.; Edginton, A., Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project, «HAEMOPHILIA», 2020, 26, pp. 384 - 400 [articolo]
Chelle, P.; Yeung, C. H. T.; Croteau, S. E.; Lissick, J.; Balasa, V.; Ashburner, C.; Park, Y. S.; Bonanad, S.; Megias-Vericat, J. E.; Nagao, A.; Wynn, T.; Corrales-Medina, F.; Tran, H.; Sharathkumar, A.; Chitlur, M.; Sarmiento, S.; Edginton, A.; Iorio, A., Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup, «CLINICAL PHARMACOKINETICS», 2020, 59, pp. 245 - 256 [articolo]
Solms, A.; Shah, A.; Berntorp, E.; Tiede, A.; Iorio, A.; Linardi, C.; Ahsman, M.; Mancuso, M. E.; Zhivkov, T.; Lissitchkov, T., Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A, «ANNALS OF HEMATOLOGY», 2020, 99, pp. 2689 - 2698 [articolo]
Schunemann, H. J.; Ventresca, M.; Crowther, M.; Briel, M.; Zhou, Q.; Noble, S.; Macbeth, F.; Griffiths, G.; Garcia, D.; Lyman, G. H.; Di Nisio, M.; Iorio, A.; Mbuagbaw, L.; Neumann, I.; Van Es, N.; Brouwers, M.; Guyatt, G.; Streiff, M. B.; Marcucci, M.; Baldeh, T.; Florez, I. D.; Alma, O. G.; Solh, Z.; Bossuyt, P. M.; Kahale, L. A.; Ageno, W.; Bozas, G.; Buller, H. R.; Lebeau, B.; Lecumberri, R.; Loprinzi, C.; Mcbane, R.; Sideras, K.; Maraveyas, A.; Pelzer, U.; Perry, J.; Klerk, C.; Agnelli, G.; Akl, E. A., Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis, «THE LANCET. HAEMATOLOGY», 2020, 7, pp. 746 - 755 [articolo]
Solms, A.; Iorio, A.; Ahsman, M. J.; Vis, P.; Shah, A.; Berntorp, E.; Garmann, D., Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach, «CLINICAL PHARMACOKINETICS», 2020, 59, pp. 605 - 616 [articolo]
Zheng, X Long; Vesely, Sara K; Cataland, Spero R; Coppo, Paul; Geldziler, Brian; Iorio, Alfonso; Matsumoto, Masanori; Mustafa, Reem A; Pai, Menaka; Rock, Gail; Russell, Lene; Tarawneh, Rawan; Valdes, Julie; Peyvandi, Flora, Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura, «JOURNAL OF THROMBOSIS AND HAEMOSTASIS», 2020, 18, pp. 2503 - 2512 [articolo]
Foroutan, F.; Guyatt, G.; Zuk, V.; Vandvik, P. O.; Alba, A. C.; Mustafa, R.; Vernooij, R.; Arevalo-Rodriguez, I.; Munn, Z.; Roshanov, P.; Riley, R.; Schandelmaier, S.; Kuijpers, T.; Siemieniuk, R.; Canelo-Aybar, C.; Schunemann, H.; Iorio, A., GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks, «JOURNAL OF CLINICAL EPIDEMIOLOGY», 2020, 121, pp. 62 - 70 [articolo]
Zheng, X. L.; Vesely, S. K.; Cataland, S. R.; Coppo, P.; Geldziler, B.; Iorio, A.; Matsumoto, M.; Mustafa, R. A.; Pai, M.; Rock, G.; Russell, L.; Tarawneh, R.; Valdes, J.; Peyvandi, F., ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura, «JOURNAL OF THROMBOSIS AND HAEMOSTASIS», 2020, 18, pp. 2486 - 2495 [articolo]
Zheng, X. L.; Vesely, S. K.; Cataland, S. R.; Coppo, P.; Geldziler, B.; Iorio, A.; Matsumoto, M.; Mustafa, R. A.; Pai, M.; Rock, G.; Russell, L.; Tarawneh, R.; Valdes, J.; Peyvandi, F., ISTH guidelines for treatment of thrombotic thrombocytopenic purpura, «JOURNAL OF THROMBOSIS AND HAEMOSTASIS», 2020, 18, pp. 2496 - 2502 [articolo]
